ASTRAZENECA has announced the second wave of arrivals to the BioHub at its Alderley Park site in Cheshire.
Gentronix Limited, Cyprotex Discovery Limited, Bionow, OncoTherics Limited, Integral Finance and The Research Network will join the tenants at the BioHub, which was set up by the firm as a collaborative R&D centre in which bioscience businesses can take advantage of Alderley Park’s scientific heritage and state-of-the-art research facilities.
Clr Michael Jones, the leader of Cheshire East Council, who has been instrumental in the AstraZeneca taskforce group, welcomed the confirmation of more companies joining the BioHub.
He said: “When David Rutley MP and I met with AstraZeneca in the summer we started the hub and we were confident the offer was going to be unique.
“When AstraZeneca first announced they were going to close and move to Cambridge, we came together to ensure that 700 jobs were retained through negotiations and we were in a position so that tenants could move in quickly.
“Cheshire East supports AstraZeneca in its move to Cambridge but we are aware the idea of a unique life science and medical hub was always the right thing for Alderley Park.”
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here